{"id":"standard-concomitant-therapy","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Fatigue"},{"rate":"10-20%","effect":"Nausea"},{"rate":"5-10%","effect":"Diarrhea"},{"rate":"5-10%","effect":"Vomiting"},{"rate":"5-10%","effect":"Anemia"},{"rate":"5-10%","effect":"Thrombocytopenia"},{"rate":"5-10%","effect":"Neutropenia"},{"rate":"5-10%","effect":"Anorexia"},{"rate":"5-10%","effect":"Weight loss"},{"rate":"5-10%","effect":"Hypertension"}]},"_chembl":{"chemblId":"CHEMBL261657","moleculeType":"Small molecule","molecularWeight":"405.37"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"The exact mechanism of standard concomitant therapy is not well-defined, as it typically involves a combination of medications with different mechanisms of action. Each medication in the combination may have a different target or mechanism, but together they work to achieve a therapeutic effect.","oneSentence":"Standard concomitant therapy involves administering multiple medications together to treat a condition.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T01:36:05.223Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Metastatic non-small cell lung cancer, PD-L1 positive"}]},"trialDetails":[{"nctId":"NCT04466488","phase":"NA","title":"Prevent TB: Choice Architecture for TPT Delivery","status":"COMPLETED","sponsor":"Johns Hopkins University","startDate":"2021-09-15","conditions":"HIV/AIDS, Tuberculosis","enrollment":50798},{"nctId":"NCT07492771","phase":"PHASE1","title":"MP101 in Adults With Acute Pseudomonas Aeruginosa Pneumonia","status":"NOT_YET_RECRUITING","sponsor":"MicrobiotiX Co., Ltd","startDate":"2026-03","conditions":"Pneumonia - Bacterial, Pseudomonas Aeruginosa Infection","enrollment":18},{"nctId":"NCT07353671","phase":"PHASE2, PHASE3","title":"Topical Periplaneta Americana-Derived Meilian Fuxin Liquid for Radiation Dermatitis","status":"RECRUITING","sponsor":"West China Hospital","startDate":"2026-03-01","conditions":"Radiation-induced Dermatitis","enrollment":60},{"nctId":"NCT06805305","phase":"PHASE2","title":"DOC1021 Dendritic Cell Immunotherapy for Treatment of Newly Diagnosed Adult Glioblastoma (GBM)","status":"RECRUITING","sponsor":"Diakonos Oncology Corporation","startDate":"2025-03-17","conditions":"Glioblastoma (GBM)","enrollment":180},{"nctId":"NCT07448519","phase":"NA","title":"Colonic Delivery of DIM and Perilla Oil on Gut Hormones and Food Intake in Obesity","status":"COMPLETED","sponsor":"Queen Mary University of London","startDate":"2023-06-13","conditions":"Obesity & Overweight, Appetite Regulation","enrollment":20},{"nctId":"NCT03633123","phase":"PHASE2","title":"D-PLEX 310: Safety and Efficacy of D-PLEX in the Prevention of Post Abdominal Surgery Incisional Infection","status":"COMPLETED","sponsor":"PolyPid Ltd.","startDate":"2018-10-04","conditions":"Abdominal Surgery, Colon Surgery, Post-Op Infection","enrollment":202},{"nctId":"NCT03663335","phase":"PHASE2","title":"Study of Efficacy, Safety, Tolerability, Pharmacokinetic (PK) and Pharmacodynamic (PD) of an Anti-CD40 Monoclonal Antibody, CFZ533, in Kidney Transplant Recipients","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2018-11-28","conditions":"Kidney Transplantation","enrollment":418},{"nctId":"NCT05318274","phase":"NA","title":"Hypofractionated Radiation Therapy vs Standard Treatment in Breast Cancer.","status":"ACTIVE_NOT_RECRUITING","sponsor":"Coordinación de Investigación en Salud, Mexico","startDate":"2021-04-26","conditions":"Ductal Breast Carcinoma in Situ, Invasive Breast Cancer, Early-stage Breast Cancer","enrollment":72},{"nctId":"NCT05436418","phase":"PHASE1, PHASE2","title":"The Lowest Effective Dose of Post-Transplantation Cyclophosphamide in Combination With Sirolimus and Mycophenolate Mofetil as Graft-Versus-Host Disease Prophylaxis After Reduced Intensity Conditioning and Peripheral Blood Stem Cell Transplantation","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2022-11-18","conditions":"Peripheral Blood Stem Cell Transplantation, Hematopoietic Stem Cell Transplantation","enrollment":260},{"nctId":"NCT07225621","phase":"PHASE2","title":"Adjuvant Temozolomide ± 5-Aminolevulinic Acid + Low Intensity Diffuse Ultrasound Sonodynamic Therapy System for Newly Diagnosed Glioblastoma","status":"RECRUITING","sponsor":"Alpheus Medical, Inc.","startDate":"2026-01-28","conditions":"Glioblastoma, GBM","enrollment":103},{"nctId":"NCT07479407","phase":"NA","title":"Effect of Pre-operative Exercise Training on Cardiorespiratory Fitness in Patients With Locally Advanced Non-small Cell Lung Cancer Undergoing Induction Chemo-immunotherapy Followed by Surgery - a Randomized Controlled Study","status":"NOT_YET_RECRUITING","sponsor":"Hôpital du Valais","startDate":"2026-04","conditions":"Locally Advanced Non-small Cell Lung Cancer (NSCLC)","enrollment":74},{"nctId":"NCT04016142","phase":"PHASE2","title":"Carboplatin-Paclitaxel Adjuvant Chemotherapy in the Treatment of Locally Advanced Cervical Cancer","status":"TERMINATED","sponsor":"Centre Oscar Lambret","startDate":"2020-07-15","conditions":"Locally Advanced Cancer, Cervical Cancer","enrollment":21},{"nctId":"NCT06561360","phase":"PHASE2","title":"A Study of Vemurafenib and Obinutuzumab Compared to Cladribine and Rituximab in People With Hairy Cell Leukemia (HCL)","status":"RECRUITING","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2024-09-09","conditions":"Hairy Cell Leukemia","enrollment":86},{"nctId":"NCT06859424","phase":"PHASE2","title":"A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation","status":"RECRUITING","sponsor":"Center for International Blood and Marrow Transplant Research","startDate":"2025-07-25","conditions":"AML (Acute Myelogenous Leukemia), Acute Lymphoid Leukemia (ALL), Acute Leukemia (Category)","enrollment":358},{"nctId":"NCT04291196","phase":"NA","title":"Virtual Reality to Reduce Pre-procedure Anxiety Prior ECT","status":"ACTIVE_NOT_RECRUITING","sponsor":"Sunnybrook Health Sciences Centre","startDate":"2020-11-27","conditions":"ECT, Electroconvulsive Therapy, Virtual Reality","enrollment":64},{"nctId":"NCT05109728","phase":"PHASE1","title":"A Dose Finding Study of [177Lu]Lu-DOTA-TATE in Newly Diagnosed Glioblastoma in Combination With Standard of Care and in Recurrent Glioblastoma as a Single Agent.","status":"ACTIVE_NOT_RECRUITING","sponsor":"Novartis Pharmaceuticals","startDate":"2022-05-10","conditions":"Glioblastoma","enrollment":65},{"nctId":"NCT01165333","phase":"PHASE1","title":"Cilengitide in Combination With Irradiation in Children With Diffuse Intrinsic Pontine Glioma","status":"COMPLETED","sponsor":"Centre Oscar Lambret","startDate":"2010-09-06","conditions":"Diffuse Intrinsic Pontine Glioma","enrollment":32},{"nctId":"NCT07472868","phase":"PHASE3","title":"Neoadjuvant FOLFOXIRI and Chemoradiotherapy Versus Neoadjuvant CAPOX/FOLFOX and Chemoradiotherapy Followed by Surgery or a Watch-and-Wait Approach in High Risk Locally Advanced Rectal Cancer","status":"NOT_YET_RECRUITING","sponsor":"J. W. A. Burger","startDate":"2026-03-03","conditions":"Locally Advanced Rectal Carcinoma","enrollment":394},{"nctId":"NCT04175600","phase":"PHASE3","title":"A Study of Selexipag as Add-On Treatment to Standard of Care in Children With Pulmonary Arterial Hypertension","status":"ACTIVE_NOT_RECRUITING","sponsor":"Actelion","startDate":"2020-01-16","conditions":"Hypertension, Pulmonary","enrollment":138},{"nctId":"NCT07466056","phase":"","title":"Application of Non-inductive Intelligent Physical Sign Monitoring Equipment Based on Flexible Electronic Devices in the Diagnosis and Treatment of Cardiovascular Diseases","status":"RECRUITING","sponsor":"Beijing Anzhen Hospital","startDate":"2024-10-01","conditions":"Cardiovascular Disease","enrollment":1100},{"nctId":"NCT07013214","phase":"NA","title":"Rehabilitation With Dual-task Exercises to Improve Balance in Patients With Parkinson's Disease","status":"RECRUITING","sponsor":"G. d'Annunzio University","startDate":"2025-07-07","conditions":"Parkinson Disease (PD), Postural Balance","enrollment":74},{"nctId":"NCT07467746","phase":"PHASE2","title":"Research of Traditional Chinese Medicine Oral Preparation of C. Cicadae in the Treatment of ALS Patients With Elevated Plasma Sphingolipids","status":"NOT_YET_RECRUITING","sponsor":"The Third Xiangya Hospital of Central South University","startDate":"2026-04","conditions":"Amyotrophic Lateral Sclerosis","enrollment":84},{"nctId":"NCT06382818","phase":"NA","title":"Personalization of Breast Radiotherapy According to Loco-regional Recurrence Risk and Toxicity Probability","status":"RECRUITING","sponsor":"Institut du Cancer de Montpellier - Val d'Aurelle","startDate":"2025-03-06","conditions":"Breast Cancer","enrollment":854},{"nctId":"NCT06365437","phase":"PHASE2","title":"A Dose Escalation Study of TCD601 Compared to ATG in de Novo Renal Transplantation","status":"TERMINATED","sponsor":"ITB-Med LLC","startDate":"2021-06-06","conditions":"Kidney Transplantation","enrollment":33},{"nctId":"NCT07032038","phase":"PHASE1, PHASE2","title":"First In Human Randomised Trial of Rincell-1 in Adults With a Cochlear Implant","status":"NOT_YET_RECRUITING","sponsor":"Rinri Therapeutics","startDate":"2026-05","conditions":"Sensorineural Hearing Loss, Presbyacusis, Auditory Neuropathy","enrollment":20},{"nctId":"NCT06168500","phase":"NA","title":"Narrow Implants Vs Standard Implants With Simultaneous GBR","status":"COMPLETED","sponsor":"Universitat Internacional de Catalunya","startDate":"2021-07-12","conditions":"Narrow Implant, Dental Implant, Bone Regeneration","enrollment":30},{"nctId":"NCT07217301","phase":"PHASE3","title":"IBI363 vs Docetaxel in Patients With Advanced Squamous Lung Cancer After Standard Treatments Have Failed","status":"RECRUITING","sponsor":"Fortvita Biologics (USA)Inc.","startDate":"2025-11-26","conditions":"iO Resistant sqNSCLC","enrollment":600},{"nctId":"NCT07456917","phase":"NA","title":"Effects of BREA and MFT Expansion Appliances on Upper Airway Dimensions","status":"COMPLETED","sponsor":"Medical University of Silesia","startDate":"2020-02-01","conditions":"Maxillary Constriction in Growing Children, Transverse Maxillary Deficiency, Upper Airway Morphology in Children","enrollment":79},{"nctId":"NCT07258394","phase":"PHASE3","title":"Clinical Study for Dimethyl Fumarate in Preserving Islet β-Cell Function in Type 1 Diabetes Mellitus","status":"RECRUITING","sponsor":"Nanjing Medical University","startDate":"2026-01-27","conditions":"Type 1 Diabetes","enrollment":90},{"nctId":"NCT07448116","phase":"PHASE1, PHASE2","title":"Study of MCLA-129 in Combination With Ensartinib in Patients With Advanced Solid Tumors.","status":"RECRUITING","sponsor":"Betta Pharmaceuticals Co., Ltd.","startDate":"2026-01-31","conditions":"Solid Advanced Tumor","enrollment":164},{"nctId":"NCT06935344","phase":"","title":"Evaluation of Polygenic Risk Score for Epithelial OVarian cancEr Risk Prediction: the PROVE Study","status":"RECRUITING","sponsor":"Catholic University of the Sacred Heart","startDate":"2025-06-01","conditions":"Ovarian Cancer","enrollment":1300},{"nctId":"NCT05681195","phase":"PHASE2","title":"Zanubrutinib With Pemetrexed to Treat Relapsed/Refractory Primary and Secondary Central Nervous System (CNS) Lymphomas","status":"RECRUITING","sponsor":"Baptist Health South Florida","startDate":"2024-04-25","conditions":"Primary Central Nervous System Lymphoma, Secondary Central Nervous System Lymphoma, Relapsed Cancer","enrollment":15},{"nctId":"NCT07432919","phase":"","title":"Evaluation of the Diagnostic Capacity of a Smart Mattress Versus Conventional Polysomnography","status":"NOT_YET_RECRUITING","sponsor":"Hospital San Pedro de Logroño","startDate":"2026-11-17","conditions":"Obstructive Sleep Apnea (OSA)","enrollment":500},{"nctId":"NCT03633708","phase":"PHASE3","title":"A Trial of Etelcalcetide in Pediatric Participants With Secondary Hyperparathyroidism and Chronic Kidney Disease on Hemodialysis","status":"RECRUITING","sponsor":"Amgen","startDate":"2019-04-29","conditions":"Secondary Hyperparathyroidism, Chronic Kidney Disease","enrollment":56},{"nctId":"NCT04602533","phase":"PHASE2","title":"Efficacy and Safety of Standard of Care Plus Durvalumab in Patients With Limited Disease Small Cell Lung Cancer (DOLPHIN)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Michael Hopp","startDate":"2020-12-21","conditions":"Small Cell Lung Cancer Limited Stage","enrollment":105},{"nctId":"NCT07066371","phase":"NA","title":"The Effect of Emotional Freedom Technique on Patients Receiving Preventive Foot Care","status":"COMPLETED","sponsor":"Bitlis Eren University","startDate":"2025-04-15","conditions":"Limb Injury, Limb Ischemia, Complication Diabetic","enrollment":60},{"nctId":"NCT06263283","phase":"NA","title":"Impact of an Educational Physiotherapy-Yoga Intervention on Perceived Stress in Women Treated With Brachytherapy for Cervical Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"Institut du Cancer de Montpellier - Val d'Aurelle","startDate":"2024-06-03","conditions":"Cervical Cancer, Brachytherapy","enrollment":98},{"nctId":"NCT07427225","phase":"NA","title":"Dual-Task vs. Multicomponent Exercise in Institutionalized Seniors","status":"NOT_YET_RECRUITING","sponsor":"Instituto Politécnico de Leiria","startDate":"2026-03-01","conditions":"Fear of Falling","enrollment":54},{"nctId":"NCT07257705","phase":"NA","title":"Pilot Trial of a Clinical Decision-Support App for Managing Emergencies Among Clinicians in a Rural Ugandan Hospital","status":"COMPLETED","sponsor":"University of Milano Bicocca","startDate":"2026-02-06","conditions":"Diarrhea Infectious, Seizures, Emergency Care","enrollment":15},{"nctId":"NCT05588895","phase":"NA","title":"Picture of Incidental Calcium To Understand Risk Estimate (PICTURE) Trial","status":"COMPLETED","sponsor":"Stanford University","startDate":"2024-01-08","conditions":"Coronary Artery Calcification","enrollment":202},{"nctId":"NCT07177079","phase":"PHASE1","title":"High-dose Ascorbate (HDA) in Combination With Standard of Care Azacitidine and Venetoclax in Acute Myeloid Leukemia (AML)","status":"NOT_YET_RECRUITING","sponsor":"Kittika Poonsombudlert","startDate":"2026-05-31","conditions":"Acute Myeloid Leukemia","enrollment":30},{"nctId":"NCT07423260","phase":"NA","title":"Evaluation of a Digital Neurorehabilitation Program Using Exergames for Adults With Mild Cognitive Impairment","status":"NOT_YET_RECRUITING","sponsor":"European University of Madrid","startDate":"2026-03","conditions":"Mild Cognitive Impairment","enrollment":38},{"nctId":"NCT05720130","phase":"PHASE1, PHASE2","title":"Phase Ib/IIa Dose Escalation and Expansion Study of [²¹²Pb]Pb-ADVC001 in Metastatic Prostate Cancer (TheraPb - Phase I/II Study).","status":"RECRUITING","sponsor":"AdvanCell Pty Limited","startDate":"2023-03-15","conditions":"Prostate Cancer, Metastatic Castration-resistant Prostate Cancer, Metastatic Hormone Sensitive Prostate Cancer","enrollment":100},{"nctId":"NCT05721248","phase":"PHASE2","title":"STOP-HER2: Stopping Trastuzumab in HER2+ MBC","status":"ACTIVE_NOT_RECRUITING","sponsor":"Dana-Farber Cancer Institute","startDate":"2023-04-19","conditions":"Breast Cancer, Metastatic Breast Cancer, HER2-positive Breast Cancer","enrollment":82},{"nctId":"NCT07419802","phase":"","title":"OxiCLEAR (Oxiris Cytokines and Endotoxin Adsorption Rate) Study","status":"RECRUITING","sponsor":"Pauls Stradins Clinical University Hospital","startDate":"2026-03-01","conditions":"Sepsis, Septic Shock, Blood Purification","enrollment":29},{"nctId":"NCT06750549","phase":"NA","title":"Mobile Application for Patient Engagement and Physician-Directed Remote Management of Heart Failure","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Michigan","startDate":"2025-02-18","conditions":"Heart Failure","enrollment":130},{"nctId":"NCT07407192","phase":"NA","title":"Toxicity Outcomes of Simultaneous Integrated Boost in Adjuvant Breast Radiotherapy Acronym","status":"COMPLETED","sponsor":"Institute of Oncology Ljubljana","startDate":"2019-01-01","conditions":"Breast Cancer","enrollment":93},{"nctId":"NCT03051464","phase":"PHASE2, PHASE3","title":"No Surgery Trial / Two Dose-escalation Strategies","status":"RECRUITING","sponsor":"Sir Mortimer B. Davis - Jewish General Hospital","startDate":"2017-04-25","conditions":"Stage II Rectal Cancer","enrollment":131},{"nctId":"NCT07415486","phase":"NA","title":"Immediate Implants in Front Teeth With Bone Loss: Regeneration and Temporary Crown in a Randomized Clinical Study","status":"NOT_YET_RECRUITING","sponsor":"Universitat Internacional de Catalunya","startDate":"2026-04-01","conditions":"Immediate Dental Implant Placement, Connective Tissue Graft, Connective Tissue Graft Harvesting","enrollment":24},{"nctId":"NCT05782335","phase":"","title":"Analysis of T and B Cell Repertoire Changes in Response to Orencia® (Abatacept) in Rheumatoid Arthritis","status":"RECRUITING","sponsor":"Hospital for Special Surgery, New York","startDate":"2022-11-01","conditions":"Rheumatoid Arthritis","enrollment":72},{"nctId":"NCT07405593","phase":"NA","title":"Head Up Position and Murottal Therapy in Stroke Patients","status":"NOT_YET_RECRUITING","sponsor":"Universitas Muhammadiyah Surakarta","startDate":"2026-03-01","conditions":"Stroke","enrollment":112},{"nctId":"NCT06024603","phase":"NA","title":"Individualized Treatments in Adults With Relapsed/Refractory Cancers","status":"ACTIVE_NOT_RECRUITING","sponsor":"Case Comprehensive Cancer Center","startDate":"2023-11-20","conditions":"Refractory Cancer, Relapsed Cancer","enrollment":36},{"nctId":"NCT05412225","phase":"PHASE1","title":"A Study of an Alternative Treatment Approach (Preoperative Radiotherapy, Then Mastectomy, Then Immediate Reconstruction Surgery) in People With T4 Breast Cancer","status":"RECRUITING","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2022-06-06","conditions":"Breast Cancer, Invasive Breast Cancer","enrollment":60},{"nctId":"NCT04478279","phase":"PHASE1, PHASE2","title":"A Phase 1-2 Study of ST101 in Patients With Advanced Solid Tumors","status":"ACTIVE_NOT_RECRUITING","sponsor":"Sapience Therapeutics","startDate":"2020-07-01","conditions":"Glioblastoma, Melanoma Stage IV, Breast Cancer","enrollment":125},{"nctId":"NCT07391618","phase":"PHASE2","title":"Clinical Study on the First-line Treatment of Advanced Colorectal Cancer With Simultaneous Infusion of Levozolinate for Injection and 5-FU","status":"RECRUITING","sponsor":"Chinese PLA General Hospital","startDate":"2025-05-15","conditions":"Advanced Colorectal Cancer","enrollment":583},{"nctId":"NCT05488626","phase":"NA","title":"Daily Adaptive Radiation Therapy: An Individualized Approach for Stage III Lung Cancer","status":"WITHDRAWN","sponsor":"Varian, a Siemens Healthineers Company","startDate":"2022-10-20","conditions":"Stage III Non-small Cell Lung Cancer","enrollment":""},{"nctId":"NCT04855422","phase":"","title":"Assessing Benchmarks For Allosure And Allomap Testing in Simultaneous Kidney & Pancreas Transplant Recipients.","status":"ACTIVE_NOT_RECRUITING","sponsor":"Montefiore Medical Center","startDate":"2021-07-14","conditions":"Transplant; Complication, Rejection","enrollment":42},{"nctId":"NCT04587128","phase":"PHASE2","title":"Early-Line Anti-EGFR Therapy to Facilitate Retreatment for Select Patients With mCRC","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Wisconsin, Madison","startDate":"2020-10-19","conditions":"Metastatic Colorectal Cancer","enrollment":34},{"nctId":"NCT07389278","phase":"PHASE1, PHASE2","title":"Combination ADI-PEG 20, TMZ, and RT for Treatment of Newly Diagnosed High-grade Glioma (HGG)","status":"NOT_YET_RECRUITING","sponsor":"Sabine Mueller, MD, PhD","startDate":"2026-03-09","conditions":"Glioblastoma, High-Grade Glioma (WHO III-IV), High-grade Glioma","enrollment":97},{"nctId":"NCT07325721","phase":"PHASE2","title":"Hypofractionated Radiotherapy With a Focal Microboost for High-Risk and Locally Advanced Prostate Cancer","status":"RECRUITING","sponsor":"Medical University of South Carolina","startDate":"2026-02-02","conditions":"Prostate Cancer, Prostate Cancer Patients Treated by Radiotherapy","enrollment":46},{"nctId":"NCT03040999","phase":"PHASE3","title":"Study of Pembrolizumab (MK-3475) or Placebo With Chemoradiation in Participants With Locally Advanced Head and Neck Squamous Cell Carcinoma (MK-3475-412/KEYNOTE-412)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2017-04-05","conditions":"Head and Neck Neoplasms","enrollment":804},{"nctId":"NCT05653635","phase":"PHASE2","title":"Contribution From PET-DOPA in Glioblastoma Re-irradiation - A Randomized Phase II Study","status":"RECRUITING","sponsor":"Centre Paul Strauss","startDate":"2026-03-01","conditions":"Glioblastoma","enrollment":54},{"nctId":"NCT07384143","phase":"NA","title":"Cognitive Recovery Via Sensor-based Robotic Upper Limb Rehabilitation in Neurological Disorders","status":"RECRUITING","sponsor":"IRCCS Centro Neurolesi Bonino Pulejo","startDate":"2025-02-11","conditions":"PARKINSON DISEASE (Disorder), Multiple Sclerosis, Stroke","enrollment":189},{"nctId":"NCT03594487","phase":"PHASE1","title":"Fecal Microbiota Transplantation (FMT) of FMP30 in Relapsing-Remitting Multiple Sclerosis","status":"TERMINATED","sponsor":"Jeffrey Gelfand","startDate":"2018-11-16","conditions":"Relapsing Remitting Multiple Sclerosis","enrollment":5},{"nctId":"NCT07378306","phase":"PHASE2","title":"FMD and Neoadjuvant Chemo-immunotherapy in TNBC","status":"NOT_YET_RECRUITING","sponsor":"Sun Yat-sen University","startDate":"2026-02-01","conditions":"Breast Cancer","enrollment":80},{"nctId":"NCT04997018","phase":"PHASE2","title":"A Study of MRI-guided High-dose Radiation Therapy in Prostate Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2021-08-04","conditions":"Prostate Cancer","enrollment":91},{"nctId":"NCT07372300","phase":"PHASE3","title":"Modulated Electro-Hyperthermia in Combination With Multimodal Therapy for Locally Advanced Rectal Cancer","status":"RECRUITING","sponsor":"Shih-Kai Hung","startDate":"2025-09-23","conditions":"Locally Advanced Rectal Carcinoma","enrollment":126},{"nctId":"NCT04402151","phase":"PHASE2","title":"Study of PSMA PET/MR Guided Stereotactic Body Radiation Therapy With Simultaneous Integrated Boost (SBRT-SIB) for High-Intermediate and High Risk Prostate Cancer","status":"RECRUITING","sponsor":"Weill Medical College of Cornell University","startDate":"2020-06-30","conditions":"Prostate Cancer","enrollment":50},{"nctId":"NCT05063201","phase":"PHASE2","title":"Cariprazine for Comorbid Cocaine and Opioid Use Disorder","status":"COMPLETED","sponsor":"Kyle Kampman","startDate":"2022-08-05","conditions":"Opioid-use Disorder, Cocaine Use Disorder","enrollment":26},{"nctId":"NCT07362693","phase":"","title":"A Cohort Study of the Efficacy and Safety of Biologics in Patients With ABPA","status":"NOT_YET_RECRUITING","sponsor":"Qianfoshan Hospital","startDate":"2025-12-31","conditions":"ABPA, Biologics, Allergic Bronchopulmonary Aspergillosis (ABPA)","enrollment":50},{"nctId":"NCT03377491","phase":"PHASE3","title":"Effect of Tumor Treating Fields (TTFields, 150 kHz) as Front-Line Treatment of Locally-advanced Pancreatic Adenocarcinoma Concomitant With Gemcitabine and Nab-paclitaxel (PANOVA-3)","status":"COMPLETED","sponsor":"NovoCure Ltd.","startDate":"2018-05-10","conditions":"Pancreas Adenocarcinoma","enrollment":571},{"nctId":"NCT07279259","phase":"PHASE2","title":"Thrombolysis in Early Acute Ischemic Stroke Trial-Blood Pressure Management","status":"RECRUITING","sponsor":"Shanghai East Hospital","startDate":"2026-01-15","conditions":"Stroke, Acute Ischemic Stroke, Thrombolysis","enrollment":340},{"nctId":"NCT07345702","phase":"","title":"Basilar Artery Occlusion Chinese Endovascular Registry in Patients With Large-Core Infarct","status":"NOT_YET_RECRUITING","sponsor":"Xuanwu Hospital, Beijing","startDate":"2026-01-31","conditions":"Basilar Artery Occlusion, Ischemic Stroke, Large Core Infarct","enrollment":518},{"nctId":"NCT04471987","phase":"PHASE1","title":"Safety and Early Signs of Efficacy of IL12-L19L19.","status":"RECRUITING","sponsor":"Philogen S.p.A.","startDate":"2020-07-01","conditions":"Advanced Solid Tumor, Metastatic Solid Tumor","enrollment":80},{"nctId":"NCT02179086","phase":"PHASE2","title":"Dose-Escalated Photon IMRT or Proton Beam Radiation Therapy Versus Standard-Dose Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"NRG Oncology","startDate":"2014-12-04","conditions":"Glioblastoma","enrollment":606},{"nctId":"NCT07276477","phase":"NA","title":"Inspiratory Muscle Training After Stroke","status":"RECRUITING","sponsor":"Uşak University","startDate":"2026-01-12","conditions":"Stroke, Exercise, Pulmonary","enrollment":54},{"nctId":"NCT05577741","phase":"NA","title":"Effect of the Enriched Environment on the Risk of Relapse","status":"COMPLETED","sponsor":"Centre Hospitalier Henri Laborit","startDate":"2022-11-29","conditions":"Alcoholic Relapse","enrollment":135},{"nctId":"NCT07335237","phase":"PHASE2","title":"Clinical Study on the Prevention and Treatment of Postoperative Gastrointestinal Dysfunction by Acupuncture Under ERAS Management Based on Artificial Intelligence Monitoring","status":"COMPLETED","sponsor":"Jiangsu Province Hospital of Traditional Chinese Medicine","startDate":"2022-09-01","conditions":"Colectomy, Colectomy Left/Right/Total Under Laparotomy, Cancer","enrollment":70},{"nctId":"NCT05871021","phase":"PHASE2","title":"Protective VEGF Inhibition for Isotoxic Dose Escalation in Glioblastoma","status":"RECRUITING","sponsor":"University Hospital Tuebingen","startDate":"2024-04-10","conditions":"Glioblastoma","enrollment":146},{"nctId":"NCT07221708","phase":"PHASE2, PHASE3","title":"Primary Prophylaxis of Clostridioides Difficile Infection With Oral Vancomycin","status":"NOT_YET_RECRUITING","sponsor":"University of Maryland, Baltimore","startDate":"2026-03-01","conditions":"Clostridioides Difficile, Vancomycin Resistance Enterococcus Faecium","enrollment":200},{"nctId":"NCT07316361","phase":"EARLY_PHASE1","title":"GYNORYLAQ™-VLINIVAL™: Ψ-Guided Personalized Neoantigen Peptide Vaccine for High-Risk Endometrial Cancer","status":"ENROLLING_BY_INVITATION","sponsor":"Biogenea Pharmaceuticals Ltd.","startDate":"2026-02-02","conditions":"Endometrial Carcinoma, Endometrial Carcinoma Stage III","enrollment":40},{"nctId":"NCT05016505","phase":"NA","title":"Supporting Smoke-Free Policy Compliance in Public Housing","status":"COMPLETED","sponsor":"Columbia University","startDate":"2022-02-03","conditions":"Smoking, Smoking Cessation, Smoking Reduction","enrollment":405},{"nctId":"NCT04843904","phase":"PHASE1","title":"Safe Accelerated Venetoclax Escalation in CLL","status":"ACTIVE_NOT_RECRUITING","sponsor":"Dana-Farber Cancer Institute","startDate":"2021-04-14","conditions":"Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma","enrollment":40},{"nctId":"NCT06456268","phase":"NA","title":"VibraCool Device to Reduce Pain and Opioid Use After Anterior Cruciate Ligament Reconstruction (ACLR)","status":"RECRUITING","sponsor":"Columbia University","startDate":"2026-06","conditions":"ACL, Opioid Use, Cryotherapy Effect","enrollment":130},{"nctId":"NCT07323823","phase":"NA","title":"The Effect of PBM on the Electrical Activity of the Brain in Stroke Patients","status":"NOT_YET_RECRUITING","sponsor":"Pusan National University Yangsan Hospital","startDate":"2025-12-31","conditions":"Post-stroke Aphasia","enrollment":66},{"nctId":"NCT07319910","phase":"","title":"Continued Access Program for Tumor Treating Fields (TTFields) Used With Chemotherapy (Gemcitabine and Nab-Paclitaxel) in Adults With Locally Advanced Pancreatic Cancer (PANOVA-3CA)","status":"TEMPORARILY_NOT_AVAILABLE","sponsor":"NovoCure GmbH","startDate":"","conditions":"Locally Advanced Pancreatic Adenocarcinoma","enrollment":""},{"nctId":"NCT05830084","phase":"PHASE1","title":"Phase Ib / Regorafenib With Conventional Chemotherapy/Newly Diagnosed Patients/ Multimetastatic Ewing Sarcoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"Gustave Roussy, Cancer Campus, Grand Paris","startDate":"2023-06-16","conditions":"Ewing Sarcoma","enrollment":23},{"nctId":"NCT06842316","phase":"","title":"Effects of Phytocannabinoids on Immune Response and Autophagy During Chronic Immune-mediated Inflammatory Diseases","status":"RECRUITING","sponsor":"Centre Hospitalier Régional d'Orléans","startDate":"2025-04-10","conditions":"Inflammatory Disorder of Immune System, Spondylitis, Ankylosing, Arthritis, Rheumatoid","enrollment":100},{"nctId":"NCT06529809","phase":"PHASE1, PHASE2","title":"Accelerated Brachytherapy Forward Chemo Radiation Therapy (ABC-RT) for Locally-advanced Cervical Cancer","status":"RECRUITING","sponsor":"Washington University School of Medicine","startDate":"2025-02-11","conditions":"Locally Advanced Cervical Carcinoma","enrollment":50},{"nctId":"NCT07299812","phase":"","title":"BRAVE-HEART: Breast Cancer Radiotherapy Using Active Breathing Coordinator to aVoid Exposure of HEART","status":"RECRUITING","sponsor":"Fondazione IRCCS Policlinico San Matteo di Pavia","startDate":"2024-05-23","conditions":"Breast Cancer, Radiotherapy","enrollment":400},{"nctId":"NCT05337982","phase":"NA","title":"Eccentric Muscle Training, Stimulation, and Biomarkers in SCI","status":"RECRUITING","sponsor":"Ohio State University","startDate":"2022-05-17","conditions":"Spinal Cord Injuries, Healthy","enrollment":49},{"nctId":"NCT07272512","phase":"PHASE4","title":"Prospective Multicenter Real-world Study of Surufatinib in Patients With Advanced Neuroendocrine Neoplasms","status":"RECRUITING","sponsor":"Shanghai Zhongshan Hospital","startDate":"2025-11-11","conditions":"Neuroendocrine Tumors, Neuroendocrine Neoplasms","enrollment":350},{"nctId":"NCT06503354","phase":"","title":"Gait Metric Validation of the Cionic Neural Sleeve","status":"COMPLETED","sponsor":"Cionic, Inc.","startDate":"2024-07-08","conditions":"Validation Study","enrollment":29},{"nctId":"NCT07290153","phase":"","title":"Psychological State, Immunotherapy Response, and Multi-Omics Signatures in TNBC","status":"RECRUITING","sponsor":"Fudan University","startDate":"2026-01-01","conditions":"Breast Cancer Female NOS, General Anxiety Disorder, Depressive Disorder","enrollment":120},{"nctId":"NCT04068909","phase":"","title":"ObseRvation After Acute Coronary Syndrome for deveLopment of trEatment Options","status":"COMPLETED","sponsor":"Central State Medical Academy","startDate":"2014-11-05","conditions":"Acute Coronary Syndrome","enrollment":1655},{"nctId":"NCT07272486","phase":"NA","title":"The Use of Virtual Reality and Music Therapy for Hypertensive Urgency","status":"COMPLETED","sponsor":"Ankara City Hospital Bilkent","startDate":"2024-08-01","conditions":"Hypertensive Urgency, Primary Hypertension","enrollment":130},{"nctId":"NCT06216301","phase":"PHASE3","title":"LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC","status":"RECRUITING","sponsor":"NovoCure GmbH","startDate":"2024-07-31","conditions":"Metastatic Non-small Cell Lung Cancer","enrollment":734},{"nctId":"NCT03013998","phase":"PHASE1, PHASE2","title":"Study of Biomarker-Based Treatment of Acute Myeloid Leukemia","status":"RECRUITING","sponsor":"Beat AML, LLC","startDate":"2016-11","conditions":"Previously Untreated Relapsed Refractory Acute Myeloid Leukemia","enrollment":3000},{"nctId":"NCT06472336","phase":"NA","title":"IntraCranial Atherosclerosis Related Large-vessel Occlusion Treated With Urgent Stenting (ICARUS)","status":"RECRUITING","sponsor":"University Hospital, Basel, Switzerland","startDate":"2025-03-31","conditions":"Stroke, Stroke, Acute Ischemic, Intracranial Atherosclerosis","enrollment":498},{"nctId":"NCT02630615","phase":"","title":"Circulating Tumor Cells (CTC) in Lung Cancer","status":"RECRUITING","sponsor":"Shadia Jalal","startDate":"2017-10-19","conditions":"Lung Neoplasms","enrollment":80}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":3,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"standard concomitant therapy","genericName":"standard concomitant therapy","companyName":"R-Pharm","companyId":"r-pharm","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Standard concomitant therapy involves administering multiple medications together to treat a condition. Used for Metastatic non-small cell lung cancer, PD-L1 positive.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}